MARKET

LIFE

LIFE

aTyr Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

10.31
+0.05
+0.49%
After Hours: 10.30 -0.01 -0.10% 19:59 09/17 EDT
OPEN
9.85
PREV CLOSE
10.26
HIGH
10.54
LOW
9.31
VOLUME
8.67M
TURNOVER
--
52 WEEK HIGH
12.97
52 WEEK LOW
2.930
MARKET CAP
174.44M
P/E (TTM)
-4.4935
1D
5D
1M
3M
1Y
5Y
Why Pharmaceutical Companies in Ovarian Cancer Drugs Market are Betting Big on R&D - Financial News Media
Palm Beach, FL - September 17, 2021 – FinancialNewsMedia.com News Commentary – The ovarian cancer drugs market consists of sales of ovarian cancer drugs to treat ovarian cancer. Ovarian cancer is caused due to abnormal growth of cells in ovary. This indust...
MENAFN · 4h ago
ATyr Pharma Shares Move Higher; Tang Capital Partners Reports In 13G Filing A 6.3% Stake In Co
-SEC Filing
SEC Filing · 9h ago
Why Pharmaceutical Companies in Ovarian Cancer Drugs Market are Betting Big on R&D
, /PRNewswire/ -- - The ovarian cancer drugs market consists of sales of ovarian cancer drugs to treat ovarian cancer. Ovarian cancer is caused due to abnormal growth of cells in ovary. This industry includes establishments that produce drugs used in che...
PR Newswire - PRF · 14h ago
Love Hemp Receives Initial Amazon Order
one of the UK's leading CBD and hemp product suppliers, is pleased to announce that it has received its initial order from Amazon.
ACCESSWIRE · 19h ago
aTyr Pharma To Present At The Oppenheimer Fall Healthcare Life Sciences And MedTech Summit On Wednesday, September 22, 2021, At 3:45 p.m. ET.
aTyr Pharma, Inc. (NASDAQ:LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that Sanjay S. Shukla, M.D., M.S., President
Benzinga · 1d ago
aTyr Pharma to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit
SAN DIEGO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that Sanjay S. Shukla, M.D., M.S....
GlobeNewswire · 1d ago
Sector Update: Health Care Stocks Largely Sitting Out Markets Recovery This Afternoon
MT Newswires · 1d ago
aTyr Pharma shares up 16% after pricing capital raise
Shares of aTyr Pharma (NASDAQ:LIFE) are up 16% in morning trading after earlier this morning pricing a nearly 9.4M share underwritten public offering expected to net $75M. The company's lead candidate, ATYR1923,
Seekingalpha · 1d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of LIFE. Analyze the recent business situations of aTyr Pharma through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average LIFE stock price target is 19.40 with a high estimate of 21.00 and a low estimate of 18.00.
EPS
Institutional Holdings
Institutions: 45
Institutional Holdings: 7.56M
% Owned: 44.68%
Shares Outstanding: 16.92M
TypeInstitutionsShares
Increased
11
1.08M
New
7
126.30K
Decreased
5
169.26K
Sold Out
3
25.17K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.49%
Pharmaceuticals & Medical Research
-0.10%
Key Executives
Non-Executive Chairman/Independent Director
John Clarke
President/Chief Executive Officer/Director
Sanjay Shukla
Chief Financial Officer
Jill Broadfoot
General Counsel/Secretary
Nancy Denyes
Director
Sara Zaknoen
Independent Director
Timothy Coughlin
Independent Director
Jane Gross
Independent Director
Svetlana Lucas
Independent Director
Paul Schimmel
No Data
About LIFE
aTyr Pharma Inc is a United States-based biotechnology company. The Company engaged in the development of medicines based on biology. The Company’s research and development efforts are concentrated on a new discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases.

Webull offers kinds of aTyr Pharma Inc stock information, including NASDAQ:LIFE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LIFE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LIFE stock methods without spending real money on the virtual paper trading platform.